Meningococcal disease, N Engl J Med, vol.344, issue.18, pp.1378-88, 2001. ,
Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century, Expert Rev Vaccines, vol.10, issue.10, pp.1477-86, 2011. ,
Global epidemiology of meningococcal disease, Vaccine, vol.27, issue.2, pp.51-63, 2009. ,
The changing and dynamic epidemiology of meningococcal disease, Vaccine, vol.30, issue.2, pp.26-36, 2012. ,
Risk of invasive meningococcal disease in men who have sex with men: lessons learned from an outbreak in Germany, PloS one, vol.11, issue.8, p.160126, 2016. ,
Meningococcal investigation Team. Risk factors for serogroup C meningococcal disease during outbreak among men who have sex with men, Emerg Infect Dis, vol.21, issue.8, pp.1458-61, 2015. ,
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales, Clin Infect Dis, vol.60, issue.4, pp.578-85, 2015. ,
, The National Institute for Public Health and the Environment. The National Immunisation Programme in the Netherlands. Surveillance and Developments in 2015-16, 2016.
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines, FEMS Microbiol Rev, vol.31, issue.1, pp.101-108, 2007. ,
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit, J Med Microbiol, vol.55, pp.887-96, 2006. ,
Epidemiology of invasive meningococcal disease in the Netherlands, 19602012: an analysis of national surveillance data, Lancet Infect Dis, vol.14, issue.9, pp.805-817, 2014. ,
, European Centre of Disease Prevention and Control. Vaccine Schedule
Invasive Neisseria meningitidis in Europe, 2006. ,
Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain, Vaccine, vol.23, issue.32, pp.4097-100, 2005. ,
Effectiveness of meningococcal serogroup C vaccine programmes, Vaccine, vol.31, issue.41, pp.4477-86, 2013. ,
DOI : 10.1016/j.vaccine.2013.07.083
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity, Clin Vaccine Immunol, vol.17, issue.5, pp.840-847, 2010. ,
Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification, Vaccine, vol.32, issue.22, pp.2604-2613, 2014. ,
DOI : 10.1016/j.vaccine.2014.03.010
Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine, J Infect, vol.66, issue.1, pp.48-56, 2013. ,
Meningococcal serogroup Y disease in Europe continuation of high importance in some European regions in 2013, Hum Vaccin Immunother, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02063970
Teenagers in England to be vaccinated against meningitis group W, BMJ, vol.350, p.1486, 2015. ,
, European Centre of Disease Prevention and Control. The Surveillance Atlas of Infectious Diseases
, Commission implementing decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/ 98/EC of the European Parliament, 2012.
The impact of meningococcal serogroup C conjugate vaccine in Scotland, Clin Infect Dis, vol.39, issue.3, pp.349-56, 2004. ,
Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, Vaccine, vol.33, issue.31, pp.3678-81, 2006. ,
Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: a time trend analysis of 1994-2012 series, Hum Vaccin Immunother, vol.12, issue.2, pp.467-73, 2016. ,
Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region, Euro Surveill, vol.20, issue.3, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02060707
Increased incidence of invasive meningococcal disease of serogroup C/clonal complex 11, Euro Surveill, vol.21, issue.12, 2015. ,
,
, Meningococcal C conjugate age-dependant long-term loss of effectiveness, Vaccine, vol.33, pp.2221-2228, 2015.
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction, Lancet, vol.364, issue.9431, pp.365-372, 2004. ,
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, issue.5, pp.737-780, 2008. ,
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis, BMJ, vol.326, issue.7385, pp.365-371, 2003. ,
Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from, Epidemiol Mikrobiol Imunol, vol.63, issue.1, pp.61-69, 2007. ,
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, Euro Surveill, vol.21, issue.45, 2015. ,
Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, Euro Surveill, vol.20, issue.9, 2014. ,
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, pp.416-441, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02093031
Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians, Clin Microbiol Infect, vol.13, issue.5, pp.550-552, 2007. ,